Allogene Therapeutics, Inc. (ALLO)
2.55
-0.10
(-3.77%)
USD |
NASDAQ |
Mar 03, 11:40
Allogene Therapeutics Research and Development Expense (Annual) : 178.66M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Agenus, Inc. | 155.53M |
| Curis, Inc. | 38.56M |
| LadRx Corp. | 0.7727M |
| Plus Therapeutics, Inc. | 10.58M |